Thursday's Midday Movers: Obamacare, Supreme Court Lifting Stocks; Methode, BioPharmX Decline

Thursday yet again contained many notable movers, including:

Winners

Cleveland BioLabs Inc CBLI - Spiked 139 percent after the biopharmaceutical company entered into a securities purchase agreement with David Davidovich for $25 million. The venture capital investor has agreed to purchase nearly 6.5 million unregistered common shares for $3.87 per share, a 35 percent premium.

Glaukos Corporation GKOS - Moved up 61 percent after its initial public offering; Glaukos offered 6 million shares of common stock at the price of $18 per share, up from expected $16-$17 per share. Glaukos has raised $108 million. Read More On Thursday's IPO's.

Real Good Solar Inc RGSE - Was up 28 percent on debt conversion news; The solar energy company reported it converted subordinated debt into Class A common stock alongside an agreement to swap substantial amounts of its Series A along with Series C warrants in return for Class A common stock.

Tenet Healthcare Corporation THC - Spiked 15 percent after the Supreme Court reported it is in favor of Obamacare. This news benefited Tenet in hopes to keep subsidies intact alongside limiting risk of bad debt expense. Bad debt expense for the company in the first quarter totaled $174 million.

Community Health Systems Inc CYH - Moved up 14 percent also on Supreme Court’s ruling in favor of Obamacare.

Losers

Methode Electronics Inc MEI - Tanked 31 percent after the company announced guidance below analyst expectations; The diversified electronics company announced that it expects to report earnings of about $2.07-$2.22 per share versus expected $2.75 per share.

World Acceptance Corporation WRLD - Was down nearly 20 percent after FBR Capital downgraded the small-loan financier company from Outperform to Market Perform.

BioPharmX Corporation BPMX - Sunk ~20 percent on a new offering of ~3.636 million shares of common stock at only $2.75, after closing at $3.25 in Wednesday’s session. BioPharmX also plans to uplist to the New York Stock Exchange market.

Insys Therapeutics Inc INSY - Was down 11 percent on high volumes trading; the stock usually trades in volumes ~44 percent lower than Thursday’s 1.44 million. In addition, Trade-Ideas LLC has identified the stock as “water-logged and getting wetter.”

Cree Inc CREE - Moved down 11 percent after the LED specialist reported an extensive business restructuring plan to react with an unappealing LED market trend.